Current situation of treatment of refractory ascites in cirrhosis
-
-
[1]郝建宇, 杨立新.肝硬化腹水病人的处理—美国肝病学会实践指南相关问答[J].中国实用内科学杂志, 2007, 27 (8) ∶567-570. [2]Moore KP, Wong F, Gines P, et al.The management of ascites incirrhosis:report on the consensus conference of the International As-cites Club[J].Hepatology, 2003, 38 (1) ∶258-66. [3]Gins P, Crdenas A, Arroyo V, et al.Management of cirrhosis andascites[J].N Engl J Med, 2004, 350∶1646-1654. [4]徐列明.肝硬化腹水的治疗[J].临床肝胆病杂志, 2004, 20 (1) ∶3-5. [5]郑盛.肝硬化顽固性腹水的治疗现状[J].胃肠病学, 2008, 13 (8) ∶379-381. [6]张艳, 齐伟.多巴胺、速尿腹腔内注射治疗肝硬化腹水[J].中国社区医师, 2006, 22 (23) ∶23-24. [7]阮冰, 何剑琴, 焦杨文, 等.前列腺素E1脂微球载体制剂治疗肝硬化顽固性腹水疗效观察[J].中国实用内科学杂志, 2003, 23 (3) ∶156-157. [8]Liu XL, Fan DM.Protective effects of prostaglandinE1 onhepatocytes[J].World J Gastroenterol, 2000, 6 (3) ∶326~329. [9]闻勤生, 张金章, 黄裕新, 等.前列腺素E1对肝硬化患者IL-6, IL-8及ALT的影响[J].第四军医大学学报, 2001, 22 (9) ∶852~854. [10]洪洋懿, 雷军, 王海林.PICC管腹腔置管联合卡托普利或氯沙坦治疗顽固性肝硬化腹水[J].广州医药, 2007, 38 (2) ∶34-35. [11]牛福玉, 房玮.应用善宁治疗肝硬化顽固性腹水的临床研究[J].中国医药导报, 2007, 4 (35) ∶36. [12]Kalambokis G, Fotopoulos A, Economou M, et al.Octreotide in thetreatment of refractory ascites of cirrhosis[J].J Gastroenterol, 2006, 41 (1) ∶118. [13]白亚文, 王仲琴.善得定治疗肝硬化难治性腹水28例[J].陕西医学杂志, 2007, 36 (11) ∶1562. [14]Gins P.Vaptans:a promising therapy in the management of ad-vanced cirrhosis[J].J Hepatol 2007, 46∶1150-1152. [15]章一凡, 朱雄雄.健脾利水汤联合腹水超滤浓缩回输治疗顽固性腹水41例[J].中国中西医结合消化杂志, 2008, 16 (1) ∶45-46. [16]钟建岳, 邱梅, 孙艳荪.消臌颗粒配合腹水超滤浓缩回输治疗顽固性肝硬化腹水50例临床观察[J].中医杂志, 2008, 49 (3) ∶218-220. [17]张伯鹏.自拟泽泻分消饮保留灌肠治疗肝硬化顽固性腹水86例[J].时珍国医国药, 2007, 18 (11) ∶2828. [18]李兆福, 李英, 杨晋辉, 等.模拟腹水腹腔回输后腹水内蛋白流向的实验研究[J].云南医药, 1999, 2 (3) ∶180-181. [19]耿云瑶.腹水超滤浓缩回输治疗顽固性腹水[J].中国医药指南, 2008, 6 (3) ∶98-99. [20]司博林, 王小明, 申瑞芳.腹水浓缩回输腹腔治疗顽固性腹水23例报告[J].江苏大学学报 (医学版) , 2006, 16 (3) ∶119-221. [21]崔敏, 熊云春, 李群.腹水浓缩不同途径回输治疗顽固性腹性临床观察[J].中国血液净化杂志, 2004, 3 (4) ∶222-223. [22]刘丽敏, 池艳春, 朱丹, 等.体外浓缩自体腹水回输治疗肝硬化顽固性腹水的临床观察[J].中华肝脏病杂志, 2004, 12 (5) ∶314. [23]顾生旺, 蒋兆荣, 万利, 等.腹水浓缩回输治疗顽固性肝硬化腹水109例次疗效观察[J].东南国防医药, 2008, 10 (1) ∶22-23. [24]Suzuki H, Stanley AJ.Current management and novel therapeuticstrategie for refractory ascites and hepatorenal syndrome[J].QJMed, 2001, 94∶293-300. [25]Runyon BA.Management of adult patients with ascites due to cir-rhosis[J].Hepatology, 2004, 39 (3) ∶841-56. [26]Alexander L G.The patient with refractory ascites[J].Best Prac-tice&Research Clinical Gastroenterology, 2007, 21 (3) ∶551-560. [27]Kuiper JJ, van Buuren HR, de Man RA.Ascites in cirrhosis:a re-view of management and complications[J].Medicine, 2007, 8 (65) ∶283-288. [28]Ishigami M, Honda T, Okumura A, et al.:Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival ofJapanese patients with cirrhosis and to determine who will benefitfrom living donor liver transplantation[J].J Gastroenterol, 2008, 43∶363-368.
本文二维码
计量
- 文章访问数: 3460
- HTML全文浏览量: 5
- PDF下载量: 1397
- 被引次数: 0